معرفی
Robert Matera, MD, is an Assistant Professor of Medicine in the Department of Internal Medicine at Yale School of Medicine, with a subspecialty in Medical Oncology and Hematology. He provides clinical care for patients with genitourinary (GU) cancers at Smilow Cancer Hospital in Waterbury and New Haven, Connecticut.
- Assistant Professor of Medicine, Yale School of Medicine
- Specialty: Medical Oncology & Hematology
- Clinical Site: Smilow Cancer Hospital at Waterbury
- Affiliations: Yale Cancer Center, Yale Medicine
Education & Training:
- BS, Tufts University (2010)
- MD, Tufts University School of Medicine (2017)
- Residency, Brown University / Rhode Island Hospital (2020), Chief Resident
- Fellowship, Yale School of Medicine
Dr. Matera's research is focused on the tumor microenvironment and its influence on cancer progression and resistance to therapy in genitourinary malignancies. He is actively engaged in the design and development of clinical trials, with a mission to expand access to innovative cancer treatments in community-based oncology settings. His work bridges clinical care and translational research to improve outcomes for patients with prostate and other GU cancers.
His research interests include tumor biology, treatment resistance mechanisms, and equitable access to cutting-edge therapies through decentralized trial models. Dr. Matera emphasizes a patient-centered approach, advocating for hope and innovation in the evolving landscape of prostate cancer treatment.
Scientific Awards and Recognition:
- Exceptional Teaching by House Staff
- Teaching Excellence Award
Dr. Matera is committed to medical education and mentoring, having been recognized for excellence during residency. While no formal advising roles or grant funding details are publicly listed, his involvement in fellowship training and clinical trial development suggests active engagement in training the next generation of oncologists. He contributes to the Prostate & Urologic Cancers Program at Yale Cancer Center and collaborates within multidisciplinary teams to advance cancer care.
He is part of active research and clinical teams focused on genitourinary oncology at Yale, working within the infrastructure of the Yale Cancer Center and Smilow Cancer Hospital to translate scientific discoveries into clinical practice.